Cytoskeleton

Shop By

25 Items

per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Product Citation
  1. KRAS G12C inhibitor

    ARS-853 is a cell-active, selective, covalent KRAS G12C inhibitor with an IC50 of 2.5 μM. ARS-853 inhibits mutant KRAS-driven signaling by binding to the GDP-bound oncoprotein and preventing activation.
  2. PDE-KRAS inhibitor

    Deltarasin is a novel small molecule inhibiting the KRAS PDEδ interaction and thus impairing oncogenic KRAS signalling.
  3. Rac family GTPase inhibitor

    EHT 1864 is an antiproliferative chemical shown to inhibit Rac family GTPases.
  4. K-Ras(G12C) inhibitor

    K-Ras(G12C) inhibitor 6 is an irreversible inhibitor of oncogenic K-Ras(G12C), subverting the native nucleotide preference to favour GDP over GTP.
  5. K-Ras(G12C) inhibitor

    K-Ras(G12C) inhibitor 12 is an allosteric inhibitor of oncogenic K-Ras(G12C).
  6. K-Ras inhibitor

    6H05 is a selective, and allosteric inhibitor of oncogenic K-Ras(G12C).
  7. K-Ras(G12C) inhibitor

    K-Ras(G12C) inhibitor 9 is an allosteric inhibitor of oncogenic K-Ras(G12C).
  8. Rab7 activator

    ML-098 is an activator of the GTP-binding protein Rab7 (EC50 = 77.6 nM).
  9. Ras-Net inhibitor

    XRP44X is a Ras-Net (Elk-3) pathway inhibitor (IC50 = 10-20 nM). Indirectly inhibits Net phosphorylation upstream of Erk1/2 activation.
  10. K-Ras inhibitor

    6H05 is a selective, and allosteric inhibitor of oncogenic mutant K-Ras(G12C).
  11. KRAS G12C inhibitor

    MRTX849 is a potent, orally-available, and mutation-selective covalent inhibitor of KRAS G12C with potential antineoplastic activity.
  12. Ral GTPase inhibitor

    RBC8 is a novel small molecule inhibitor of Ral GTPase; has IC50 of 3.5 μM in H2122 cell and 3.4 μM in H358 cell.
  13. KRAS-G12C inhibitor

    ARS-1620 is a potent, orally bioavailable covalent inhibitor of KRAS-G12C) and could achieve rapid and sustained in vivo target occupancy to induce tumor regression.
  14. MRCK inhibitor

    BDP9066 is a potent and selective MRCK inhibitor, reducing substrate phosphorylation.
  15. Rac1 inhibitor

    1A-116 is a specific Rac1 inhibitor, can prevent EGF-induced Rac1 activation and block Rac1-P-Rex1 interaction. 1A-116 can induce apoptosis and inhibit cell proliferation, migration and cycle progression in a concentration-dependent manner. 1A-116 also demonstrates a high antimetastatic activity in vivo.

  16. ROCK and MRCK inhibitor

    BDP5290 is a potent inhibitor of both ROCK and MRCK with IC50s of 5 nM, 50 nM, 10 nM and 100 nM for ROCK1, ROCK2, MRCKα and MRCKβ, respectively.
  17. mutant K-ras G12C inhibitor

    ARS-1323 is a novel inhibitor of mutant K-ras G12C.
  18. Ras inhibitor

    Antineoplaston A 10 is a Ras inhibitor potentially for the treatment of glioma, lymphoma, astrocytoma and breast cancer.
  19. pan-RAS inhibitor

    Ras-IN-3144 is a pan-RAS inhibitor which inhibits RAS signaling pathways in cancer cells and prevents the growth of RAS mutant mouse cancer xenografts.
  20. KRAS-G12C inhibitor

    MRTX1257 is a potent, selective, covalent and irreversible inhibitor of KRAS G12C, MRTX1257 inhibited KRAS dependent ERKphosphorylation in the H358cell assay with an IC50= 900 pM.
  21. K-ras G12C inhibitor

    K-Ras G12C-IN-3 is a novel and irreversible inhibitor of mutant K-ras G12C.
  22. covalent K-Ras G12C inhibitor

    K-Ras G12C-IN-2 is an irreversible covalent K-Ras G12C inhibitor.
  23. K-ras G12C inhibitor

    K-Ras G12C-IN-1 is a novel and irreversible inhibitor of mutant K-ras G12C extracted from patent WO 2014152588 A1.
  24. K-Ras(G12C) inhibitor

    6H05 TFA is a selective, and allosteric inhibitor of oncogenic mutant K-Ras(G12C).
  25. S-IIP inhibitor/KRASG12C Probe

    ARS-1323-Alkyne is a novel KRASG12C occupancy probe.

25 Items

per page
Set Descending Direction